361 related articles for article (PubMed ID: 1652110)
1. In vivo and in vitro studies on the opioidergic control of the secretion of gonadotrophin-releasing hormone and luteinizing hormone in sexually immature and adult male rats.
Leposavic G; Cover PO; Buckingham JC
Neuroendocrinology; 1991 Jun; 53(6):579-88. PubMed ID: 1652110
[TBL] [Abstract][Full Text] [Related]
2. Effects of selective opioid-receptor blockade on the hypothalamo-pituitary-adrenocortical responses to surgical trauma in the rat.
Cover PO; Buckingham JC
J Endocrinol; 1989 May; 121(2):213-20. PubMed ID: 2547002
[TBL] [Abstract][Full Text] [Related]
3. Relative effectiveness of naloxone and MR2266 in potentiating oestrogen-stimulated luteinizing hormone surges in ovariectomized female rats.
Dyer RG; Mansfield S; Dean AD
Neurosci Lett; 1984 Aug; 49(1-2):111-5. PubMed ID: 6093001
[TBL] [Abstract][Full Text] [Related]
4. Development and control of the opioid inhibition of gonadotropin secretion during the sexual maturation of the male rat.
Nazian SJ
Neuroendocrinology; 1992 Jun; 55(6):613-20. PubMed ID: 1630582
[TBL] [Abstract][Full Text] [Related]
5. Age-related differences in the sensitivity of serum luteinizing hormone to prototypic mu, kappa and delta opiate agonists and antagonists.
Cicero TJ; Meyer ER; Miller BT; Bell RD
J Pharmacol Exp Ther; 1988 Jul; 246(1):14-20. PubMed ID: 2839658
[TBL] [Abstract][Full Text] [Related]
6. CRF alters the infundibular LHRH secretory system from the medial preoptic area of female rats: possible involvement of opioid receptors.
Rivest S; Plotsky PM; Rivier C
Neuroendocrinology; 1993; 57(2):236-46. PubMed ID: 8389996
[TBL] [Abstract][Full Text] [Related]
7. The effects of opioid blockade and GnRH administration upon luteinizing hormone secretion in patients with anorexia nervosa during the stages of weight loss and weight recovery.
García-Rubí E; Vazquez-Alemán D; Mendez JP; Salinas JL; Garza-Flores J; Ponce-de-León S; Perez-Palacios G; Ulloa-Aguirre A
Clin Endocrinol (Oxf); 1992 Dec; 37(6):520-8. PubMed ID: 1286522
[TBL] [Abstract][Full Text] [Related]
8. Naloxone does not reverse the inhibitory effect of morphine on luteinizing hormone secretion in prepubescent male rats.
Cicero TJ; Nock B; O'Connor L
J Pharmacol Exp Ther; 1993 Jan; 264(1):47-53. PubMed ID: 8380870
[TBL] [Abstract][Full Text] [Related]
9. Endogenous opioids participate in the regulation of the hypothalamus-pituitary-luteinizing hormone axis and testosterone's negative feedback control of luteinizing hormone.
Cicero TJ; Schainker BA; Meyer ER
Endocrinology; 1979 May; 104(5):1286-91. PubMed ID: 374068
[TBL] [Abstract][Full Text] [Related]
10. Participation of both adrenergic and opioidergic systems in the negative feedback of adrenal progesterone on LH secretion.
Salicioni AM; Carón RW; Deis RP
Eur J Pharmacol; 1997 Aug; 332(3):283-7. PubMed ID: 9300262
[TBL] [Abstract][Full Text] [Related]
11. Peripubertal changes in the nature of the GnRH response to alpha-adrenoceptor stimulation in vitro and their modulation by testosterone.
Leposavic G; Dashwood MR; Ginsburg J; Buckingham JC
Neuroendocrinology; 1990 Jul; 52(1):82-9. PubMed ID: 1975657
[TBL] [Abstract][Full Text] [Related]
12. Changes in the responsiveness of luteinizing hormone secretion to infusion of the opioid antagonist naloxone throughout male sexual maturation.
Ulloa-Aguirre A; Mendez JP; Gonzalez-Castillo A; Carranza-Lira S; Garza-Flores J; Peres-Palacios G
Clin Endocrinol (Oxf); 1988 Jul; 29(1):17-28. PubMed ID: 3073879
[TBL] [Abstract][Full Text] [Related]
13. Opioids modify the release of LH at the pituitary level: in vitro studies with entire rat pituitaries.
Dragatsis I; Papazafiri P; Zioudrou C; Gerozissis K
J Endocrinol; 1995 May; 145(2):263-70. PubMed ID: 7616159
[TBL] [Abstract][Full Text] [Related]
14. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
[TBL] [Abstract][Full Text] [Related]
15. Ontogeny of the opioid-mediated control of reproductive endocrinology in the male and female rat.
Cicero TJ; Schmoeker PF; Meyer ER; Miller BT; Bell RD; Cytron SM; Brown CC
J Pharmacol Exp Ther; 1986 Mar; 236(3):627-33. PubMed ID: 3512817
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone suppresses gonadotropin-releasing hormone (GnRH) secretion and has direct pituitary effects in male rats: differential regulation of GnRH receptor and gonadotropin responses to GnRH.
Rosen H; Jameel ML; Barkan AL
Endocrinology; 1988 Jun; 122(6):2873-80. PubMed ID: 2836177
[TBL] [Abstract][Full Text] [Related]
17. Mainly mu-opiate receptors are involved in luteinizing hormone and prolactin secretion.
Panerai AE; Petraglia F; Sacerdote P; Genazzani AR
Endocrinology; 1985 Sep; 117(3):1096-9. PubMed ID: 2990867
[TBL] [Abstract][Full Text] [Related]
18. Exogenous gonadotrophin-releasing hormone (GnRH) stimulates LH secretion in male monkeys (Macaca fascicularis) treated chronically with high doses of a GnRH antagonist.
Weinbauer GF; Hankel P; Nieschlag E
J Endocrinol; 1992 Jun; 133(3):439-45. PubMed ID: 1613445
[TBL] [Abstract][Full Text] [Related]
19. Opioidergic modulation of in vitro pulsatile gonadotropin-releasing hormone release from the isolated medial basal hypothalamus of the male guinea pig.
Giri M; Kaufman JM
Endocrinology; 1994 Nov; 135(5):2137-43. PubMed ID: 7956937
[TBL] [Abstract][Full Text] [Related]
20. The actions of prostaglandin E2, naloxone and testosterone on starvation-induced suppression of luteinizing hormone-releasing hormone and luteinizing-hormone secretion. In vitro and in vivo studies.
Küderling I; Dorsch G; Warnhoff M; Pirke KM
Neuroendocrinology; 1984 Dec; 39(6):530-7. PubMed ID: 6392920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
